Hormone treatment for heavy periods in teens and young adults
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This trial studies how a progestin hormone—given as an IUD or tablets—can help reduce heavy menstrual bleeding in people with certain bleeding-related conditions. It may help you by testing whether the treatment works and is practical for your situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have started menstruation and are between ages 10 and 24
- You and your clinician are planning to try progestin treatment (either an LNG IUD or NETA pills)
- Your periods fit the trial definition of heavy menstrual bleeding
- You have a known bleeding disorder or are willing/able to complete a basic check to rule one out
- If you’re under 18, a parent can provide consent and you can provide assent; if 18+, you provide consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether different types of hormonal medication (such as pills or an intrauterine device) can help manage heavy periods in adolescents and young adults. The goal is to find what works best for reducing bleeding and improving quality of life.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This study tests whether a small nerve stimulation device (tAN) worn on the ear can help reduce heavy menstrual bleeding. You will use the device during your periods and track your bleeding with provided products and an app.
This study tests a new type of intrauterine device (IUD) called LevoCept that releases a hormone to prevent pregnancy. The goal is to see how well it works, how safe it is, and whether it is comfortable for you.
This trial tests if dydrogesterone, a hormone pill, can safely help teenagers with heavy or irregular periods. If you or your child have had unusual bleeding that isn't caused by pregnancy or other medical issues, this study may provide treatment options.
This trial tests a new medicine called ALN-6400 in teenage and adult women with von Willebrand disease (a blood clotting condition) who experience heavy menstrual bleeding. The goal is to see if this treatment can reduce bleeding and improve quality of life.
Hear when a new Heavy Menstrual Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.